These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10969232)
21. Tenecteplase for acute ischemic stroke. Lyden P Int J Stroke; 2011 Dec; 6(6):509-10. PubMed ID: 22111795 [No Abstract] [Full Text] [Related]
22. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Hsieh HC; Chen CH Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644 [No Abstract] [Full Text] [Related]
23. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses". Chao AC; Po HL; Chan L Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029 [No Abstract] [Full Text] [Related]
24. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion". Behrouz R; Mutgi SA; Silver B Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241 [No Abstract] [Full Text] [Related]
30. Door-to-needle times in acute ischemic stroke: how low can we go? Smith EE; von Kummer R Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861 [No Abstract] [Full Text] [Related]
31. Breaking up is hard to do: tenecteplase in acute stroke. Schwamm LH Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503 [No Abstract] [Full Text] [Related]
32. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up]. Wahlgren NG Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940 [No Abstract] [Full Text] [Related]
33. rt-PA for ischaemic stroke: what will the next question be? Leys D; Cordonnier C Lancet; 2012 Jun; 379(9834):2320-1. PubMed ID: 22632906 [No Abstract] [Full Text] [Related]
34. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Schestatsky P; Picon PD Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546 [No Abstract] [Full Text] [Related]
35. Switched On-Expert Advice in Prehospital Thrombolysis via Telemedicine. Ebinger M; Audebert HJ JAMA Neurol; 2016 Feb; 73(2):153-4. PubMed ID: 26642263 [No Abstract] [Full Text] [Related]
36. UK drug agency announces review of use of alteplase after stroke. Cohen D; Macdonald H BMJ; 2014 Sep; 349():g5355. PubMed ID: 25179758 [No Abstract] [Full Text] [Related]
37. rtPA in acute stroke patients with history of cognitive impairment: do not hesitate to treat. Román GC; Hakim AM Neurology; 2014 Jun; 82(23):2044-5. PubMed ID: 24827496 [No Abstract] [Full Text] [Related]
38. When is enough enough? Donnan GA; Davis SM Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042 [No Abstract] [Full Text] [Related]
39. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Kleindorfer DO; Khatri P; Katzan I Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320 [No Abstract] [Full Text] [Related]
40. Breaking the 3 h barrier for treatment of acute ischaemic stroke. Donnan GA; Davis SM Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]